Search Results - technology+classifications+%3e+healthcare+portfolios+%3e+women%27s+health

12 Results Sort By:
Bea Breast Density Bioelectrical Impedance Device Attachment
This technology is a device which applies bioelectrical impedance (BIA) principles to the breast for an estimate of breast density in order to provide a new screening tool for detection of breast cancer. BIA technology is applied to the limited area of breast as opposed to whole body measurements commonly used to assess adiposity. The goal of the breast...
Published: 7/9/2024   |   Inventor(s): Jennifer Bea
Keywords(s):  
Category(s): Technology Classifications > Healthcare Portfolios > Oncology, Technology Classifications > Healthcare Portfolios > Women's Health, Technology Classifications > Medical Devices > Diagnostic
Synthesis of Novel Au(II) Dimers and Investigation of their Potential for Applications in Cancer Treatment
This invention is a method of synthesis of novel Au(II) dimer with pyridine dipyrrolinone (H2PYDP) ligands which demonstrate antiproliferative activity in ovarian cancers. This compound operates with a different mechanism than similar existing drugs allowing for novel combinational drug therapies to be created and tested. Background: It is estimated...
Published: 7/8/2024   |   Inventor(s): Elisa Tomat, Iva Habensus, Yu-Shien Sung
Keywords(s):  
Category(s): Technology Classifications > Life Sciences > Therapeutics, Technology Classifications > Healthcare Portfolios > Oncology, Technology Classifications > Healthcare Portfolios > Women's Health
Fecal Containment Obstetric Drape
This technology is an obstetric under-buttocks drape that has an additional flap located above the fluid collection portion for use during labor and delivery in childbirth. This is a one-size-fits all flap that has an adhesive lining at the top that allows for adhesion to the patient’s perineum and across the patient’s back thighs. The flap...
Published: 6/5/2024   |   Inventor(s): Cassidy Augustinovich
Keywords(s):  
Category(s): Technology Classifications > Healthcare Portfolios > Women's Health, Technology Classifications > Medical Devices
Metabolic Screening Methods for Endometrial Cancer
Researchers at the University of Arizona employed cervicovaginal lavage sampling and a global untargeted metabolomic approach to identify potential biomarkers for endometrial cancer. The study's novel approach involved linking cervicovaginal metabolite levels to crucial tumor characteristics such as size, histological grade, and myometrial invasion,...
Published: 3/1/2024   |   Inventor(s): Melissa Herbst-Kralovetz, Pawel Laniewski
Keywords(s):  
Category(s): Technology Classifications > Healthcare Portfolios > Women's Health, Technology Classifications > Life Sciences > Biomarkers, Technology Classifications > Life Sciences > Diagnostics
Phenyllactic Acid: Antimicrobial Activity against Vaginal Microbiota and Cytotoxic Properties on Human Cervical Epithelial Cells
Researchers at the University of Arizona investigated the antimicrobial properties of Phenyllactic Acid (PLA) derivatives against both commensal and Bacterial vaginosis (BV)-associated bacteria, as well as their cytotoxic effects on human cervical epithelial cells. PLA is a broad-spectrum antimicrobial compound produced by vaginal Lactobacillus species;...
Published: 1/16/2024   |   Inventor(s): Melissa Herbst-Kralovetz, Pawel Laniewski, Abhijit Date, Phoebe Crossley
Keywords(s):  
Category(s): Technology Classifications > Life Sciences > Therapeutics, Technology Classifications > Healthcare Portfolios > Women's Health, Technology Classifications > Healthcare Portfolios > Infectious Diseases
Methods for Guiding Treatments of Vulvovaginal Symptoms and Female Sexual Dysfunction
Multi-omics analysis of cervicovaginal samples has led to the identification of a specific immune mediators, metabolites, and bacteria that are associated with vulvovaginal and sexual health symptoms. These biomarkers hold the potential to be utilized in a non-invasive test that guides the treatment of vulvovaginal symptoms and female sexual dysfunction...
Published: 6/6/2024   |   Inventor(s): Melissa Herbst-Kralovetz, Pawel Laniewski
Keywords(s):  
Category(s): Technology Classifications > Healthcare Portfolios > Women's Health, Technology Classifications > Healthcare Portfolios > Reproductive Health: Obstetrics & Gynecology, Technology Classifications > Life Sciences > Biomarkers, Technology Classifications > Life Sciences > Therapeutics
A Steerable, Optically Guided System for Detection of Ureteral Injury and Ureteral Catheterization
This technology is a therapeutic and diagnostic one-time-use device to place a ureteral catheter or stent without fluoroscopic guidance. Enhancements to the device may allow detection of injury to the ureter via Optical Coherence Tomography (OCT) and treatment of nephrolithiasis via laser lithotripsy. This small-diameter ureteral catheter or stent comprises...
Published: 1/22/2024   |   Inventor(s): John Heusinkveld, Jennifer Barton, Dominique Galvez, Andrew Rocha, William Drake
Keywords(s):  
Category(s): Technology Classifications > Medical Devices > Diagnostic, Technology Classifications > Imaging & Optics > Medical Imaging, Technology Classifications > Healthcare Portfolios > Urology, Technology Classifications > Healthcare Portfolios > Women's Health
Diagnostic for Non-Invasive Screening and Early Detection of Adenomyosis
This technology is a non-invasive diagnostic for the screening and detection of adenomyosis. This could be used for women who are suffering with symptoms of chronic pelvic pain and adenomyosis for diagnosis without an invasive hysterectomy. In preliminary studies, there have been high acceptance of a particular sampling, that can provide information...
Published: 6/6/2024   |   Inventor(s): Melissa Herbst-Kralovetz, Pawel Laniewski
Keywords(s):  
Category(s): Technology Classifications, Technology Classifications > Life Sciences > Biomarkers, Technology Classifications > Life Sciences > Diagnostics, Technology Classifications > Healthcare Portfolios > Women's Health
Diagnostic for Screening and/or Predicting Women "at risk" for the Development and Progression Endometrial Cancer
This invention describes a novel method to use metabolic markers in samples obtained from cervicovaginal lavage (CVL) and machine-learning algorithms to detect patients “at risk” for endometrial cancer (EMC). Background: Endometrial cancer (EMC) is the most common gynecological cancer. The American Cancer Society estimates that in 2021...
Published: 11/16/2023   |   Inventor(s): Melissa Herbst-Kralovetz, Pawel Laniewski
Keywords(s):  
Category(s): Technology Classifications > Life Sciences > Diagnostics, Technology Classifications > Life Sciences > Biomarkers, Technology Classifications > Healthcare Portfolios > Women's Health
Diagnostic for Monitoring Response to Immunotherapies for Gynecologic Cancer
This invention is a collection of immunological checkpoint proteins and physiological markers to diagnose and potentially monitor treatments for cervical cancer. This biomarker panel would be taken using the cervicovaginal lavage method, which is less invasive than other sampling methods for cervical cancer. This diagnostic test could be used not only...
Published: 6/6/2024   |   Inventor(s): Melissa Herbst-Kralovetz, Pawel Laniewski
Keywords(s):  
Category(s): Technology Classifications > Healthcare Portfolios > Oncology, Technology Classifications > Healthcare Portfolios > Women's Health, Technology Classifications > Life Sciences > Biomarkers, Technology Classifications > Life Sciences > Diagnostics
1 2